These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 35024271)

  • 21. A SARS-CoV-2 Surveillance System in Sub-Saharan Africa: Modeling Study for Persistence and Transmission to Inform Policy.
    Post LA; Argaw ST; Jones C; Moss CB; Resnick D; Singh LN; Murphy RL; Achenbach CJ; White J; Issa TZ; Boctor MJ; Oehmke JF
    J Med Internet Res; 2020 Nov; 22(11):e24248. PubMed ID: 33211026
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Investigating connections between COVID-19 pandemic, air pollution and community interventions for Pakistan employing geoinformation technologies.
    Mehmood K; Bao Y; Petropoulos GP; Abbas R; Abrar MM; Saifullah ; Mustafa A; Soban A; Saud S; Ahmad M; Hussain I; Fahad S
    Chemosphere; 2021 Jun; 272():129809. PubMed ID: 33582510
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Nonlinearity in the relationship between COVID-19 cases and carbon damages: controlling financial development, green energy, and R&D expenditures for shared prosperity.
    Anser MK; Godil DI; Khan MA; Nassani AA; Askar SE; Zaman K; Salamun H; Sasmoko ; Indrianti Y; Abro MMQ
    Environ Sci Pollut Res Int; 2022 Jan; 29(4):5648-5660. PubMed ID: 34424465
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Public healthcare system capacity during COVID-19: A computational case study of SARS-CoV-2.
    Batabyal S; Batabyal A
    Health Sci Rep; 2021 Jun; 4(2):e305. PubMed ID: 34136660
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Financial contagion intensity during the COVID-19 outbreak: A copula approach.
    Benkraiem R; Garfatta R; Lakhal F; Zorgati I
    Int Rev Financ Anal; 2022 May; 81():102136. PubMed ID: 36536771
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Global Financial Crisis, Smart Lockdown Strategies, and the COVID-19 Spillover Impacts: A Global Perspective Implications From Southeast Asia.
    Wang C; Wang D; Abbas J; Duan K; Mubeen R
    Front Psychiatry; 2021; 12():643783. PubMed ID: 34539457
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Relationship between energy demand, financial development, and carbon emissions in a panel of 101 countries: "go the extra mile" for sustainable development.
    Vo XV; Zaman K
    Environ Sci Pollut Res Int; 2020 Jun; 27(18):23356-23363. PubMed ID: 32356058
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A prospective, randomized, single-blinded, crossover trial to investigate the effect of a wearable device in addition to a daily symptom diary for the Remote Early Detection of SARS-CoV-2 infections (COVID-RED): a structured summary of a study protocol for a randomized controlled trial.
    Brakenhoff TB; Franks B; Goodale BM; van de Wijgert J; Montes S; Veen D; Fredslund EK; Rispens T; Risch L; Dowling AV; Folarin AA; Bruijning P; Dobson R; Heikamp T; Klaver P; Cronin M; Grobbee DE;
    Trials; 2021 Oct; 22(1):694. PubMed ID: 34635140
    [TBL] [Abstract][Full Text] [Related]  

  • 29. International trade as critical parameter of COVID-19 spread that outclasses demographic, economic, environmental, and pollution factors.
    Bontempi E; Coccia M
    Environ Res; 2021 Oct; 201():111514. PubMed ID: 34139222
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Global age-sex-specific mortality, life expectancy, and population estimates in 204 countries and territories and 811 subnational locations, 1950-2021, and the impact of the COVID-19 pandemic: a comprehensive demographic analysis for the Global Burden of Disease Study 2021.
    GBD 2021 Demographics Collaborators
    Lancet; 2024 May; 403(10440):1989-2056. PubMed ID: 38484753
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effectiveness and cost-effectiveness of four different strategies for SARS-CoV-2 surveillance in the general population (CoV-Surv Study): a structured summary of a study protocol for a cluster-randomised, two-factorial controlled trial.
    Deckert A; Anders S; de Allegri M; Nguyen HT; Souares A; McMahon S; Boerner K; Meurer M; Herbst K; Sand M; Koeppel L; Siems T; Brugnara L; Brenner S; Burk R; Lou D; Kirrmaier D; Duan Y; Ovchinnikova S; Marx M; Kräusslich HG; Knop M; Bärnighausen T; Denkinger C
    Trials; 2021 Jan; 22(1):39. PubMed ID: 33419461
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The British variant of the new coronavirus-19 (Sars-Cov-2) should not create a vaccine problem.
    Conti P; Caraffa A; Gallenga CE; Kritas SK; Frydas I; Younes A; Di Emidio P; Tetè G; Pregliasco F; Ronconi G
    J Biol Regul Homeost Agents; 2021; 35(1):1-4. PubMed ID: 33377359
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identifying the Potential Causes, Consequences, and Prevention of Communicable Diseases (Including COVID-19).
    Anser MK; Islam T; Khan MA; Zaman K; Nassani AA; Askar SE; Abro MMQ; Kabbani A
    Biomed Res Int; 2020; 2020():8894006. PubMed ID: 33204725
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Interplay Between Policy and COVID-19 Outbreaks in South Asia: Longitudinal Trend Analysis of Surveillance Data.
    Welch SB; Kulasekere DA; Prasad PVV; Moss CB; Murphy RL; Achenbach CJ; Ison MG; Resnick D; Singh L; White J; Issa TZ; Culler K; Boctor MJ; Mason M; Oehmke JF; Faber JMM; Post LA
    JMIR Public Health Surveill; 2021 Jun; 7(6):e24251. PubMed ID: 34081593
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Measures implemented in the school setting to contain the COVID-19 pandemic.
    Krishnaratne S; Littlecott H; Sell K; Burns J; Rabe JE; Stratil JM; Litwin T; Kreutz C; Coenen M; Geffert K; Boger AH; Movsisyan A; Kratzer S; Klinger C; Wabnitz K; Strahwald B; Verboom B; Rehfuess E; Biallas RL; Jung-Sievers C; Voss S; Pfadenhauer LM
    Cochrane Database Syst Rev; 2022 Jan; 1(1):CD015029. PubMed ID: 35037252
    [TBL] [Abstract][Full Text] [Related]  

  • 36. SARS-CoV-2 Surveillance in the Middle East and North Africa: Longitudinal Trend Analysis.
    Post L; Marogi E; Moss CB; Murphy RL; Ison MG; Achenbach CJ; Resnick D; Singh L; White J; Boctor MJ; Welch SB; Oehmke JF
    J Med Internet Res; 2021 Jan; 23(1):e25830. PubMed ID: 33302252
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A prospective, randomized, single-blinded, crossover trial to investigate the effect of a wearable device in addition to a daily symptom diary for the remote early detection of SARS-CoV-2 infections (COVID-RED): a structured summary of a study protocol for a randomized controlled trial.
    Brakenhoff TB; Franks B; Goodale BM; van de Wijgert J; Montes S; Veen D; Fredslund EK; Rispens T; Risch L; Dowling AV; Folarin AA; Bruijning P; Dobson R; Heikamp T; Klaver P; Cronin M; Grobbee DE;
    Trials; 2021 Jun; 22(1):412. PubMed ID: 34158099
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Psychological Distress and Coronavirus Fears During the Initial Phase of the COVID-19 Pandemic in the United States.
    French MT; Mortensen K; Timming AR
    J Ment Health Policy Econ; 2020 Sep; 23(3):93-100. PubMed ID: 32853158
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prediction of the COVID-19 Pandemic for the Top 15 Affected Countries: Advanced Autoregressive Integrated Moving Average (ARIMA) Model.
    Singh RK; Rani M; Bhagavathula AS; Sah R; Rodriguez-Morales AJ; Kalita H; Nanda C; Sharma S; Sharma YD; Rabaan AA; Rahmani J; Kumar P
    JMIR Public Health Surveill; 2020 May; 6(2):e19115. PubMed ID: 32391801
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.